• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA Grants 510(k) Clearance to LivaNova’s B-Capta

    Gynesonics Appoints Susan Stimson to Its Board of Directors

    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump

    Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

    Abbott Begins Shipping Rapid COVID Self-Tests
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    FUTEK Advanced Sensor Technology Inc.

    MW Life Sciences

    Qosina Corp.

    Unicep
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS' Engineering Resources Increasingly in Demand

    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    Spectrum Plastics Group

    Trademark Plastics Inc.

    Concise Engineering

    Qosina Corp.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Creating Value by Design

    ...

    Creating Value by Design
    Related CONTENT
    • Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    • EMS' Engineering Resources Increasingly in Demand
    • Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    • Portable Medical Devices Market to Reach $100 Billion by 2027
    • BD Receives 510(k) Clearance for Pristine Catheter
    Steve Maylish, Chief Commercial Officer, Fusion Biotec; Bruce Sargeant, Founder & CEO, Fusion Biotec11.08.16
    Any development project brings difficulty in understanding what portion of the process adds value, and what just adds time. No one wants to spin their wheels when trying to get to market. Applying research and translating it into a commercial application is the key to creating value for investors. There are numerous inflection points along the way; so how can a company keep focused on a commercial product to create the most value?

    The first important inflection point is intellectual property (IP). For investors, IP ensures an investment and provides competitors a barrier to entry. There are markets where “first mover” advantage is key—endorsements by professional communities, building extensive databases, or locking up exclusive contracts provide barriers to entry. While that can be equally important for medical devices, creation of protectable IP is critical. Patents are filed early in the process and filing usually continues throughout the development process as new technologies and processes are applied.

    Investors understand the commercialization process and time required to bring a medical device to market. Since investors plan for relatively longer return-on-investment cycles and multiple rounds of funding, the technology must be protected.

    The next inflection point is moving the technology out of the lab, or creating a feasibility system. Whether the research work involves new technology, chemistry, or process, one must ask, “Can this technology be translated into a commercial product that fulfills an unmet clinical need?” Or, “What application will providers pay for?” Proving a concept’s repeatability outside the lab or feasibility in practice is the first step to commercialization.

    This is the feasibility phase for most technologies, which is experimental and attempts to create an early proof-of-concept. Before  documenting requirements, know if the concept has legs. Can the IP be converted into a breadboard concept proving feasibility?

    Here is an excellent time to retire technical risk. The technology may work in theory, but technically, risk can still be high. At this point, it’s prudent to build a rudimentary system and work out technical challenges before committing to the entire project. The learning at this stage is invaluable, because it demonstrates a commercial product’s feasibility.

    This is also the time for “fast development,” “fail early and often,” and a “trial and error” approach. This phase facilitates iterating product requirements, doing early user studies, and checking different design ideas. When formal design control starts, many unknowns have already been investigated and the technical direction is solid.

    On any project, the developer decides when to start design control. This is an important step; begin too early, and there’s insufficient information. Starting too early muddies requirements with too many “to-be-determined” mandates, puts unnecessary constraints on the team, and adds little value. Begin too late, and the risk of a complete redesign increases. Continue feasibility if the team is unsure of the initial feasibility results or needs additional testing or customer feedback.

    Sometimes a startup must demonstrate a feasibility system to raise the next round of funding. To conserve funds, the concept may be brought to a more advanced prototype without a formal design process. This helps meet a milestone and set the stage for additional funding, but this path is more costly. Some engineering work will also be repeated under formal design controls. However, the alpha prototype becomes input for the product requirements document, usually meaning a more comprehensive set of technical requirements. Keep in mind that data collected from the feasibility system (developed outside of design controls) cannot be submitted to the U.S. Food and Drug Administration (FDA). Clinical data must be collected with a documented device that is essentially identical to the device intended for sale.

    Another path is building a research unit only. Using grant funding, one company refined its imaging technology into a powerful research tool. The company designed a medical device with the knowledge it gained from use during research. In this example, the company developed new software, followed design controls, performed clinical studies, and submitted to the FDA. The company received early sales and technical experience before a formal development process, but this approach led to a longer path to market.

    How does one build the most value? For a medical design project in the startup world, it’s all about getting to market. The best value is created by developing the highest quality device in the shortest time (see “Design Tradeoffs” in September’s issue of MPO).

    Highest quality in this context means a device performing its intended function perfectly and exceeding customer expectations. This implies the company completely understands user needs, which is often not the case. At this point, gaining user feedback to define the product and the market is invaluable. It provides  a source of marketing requirements (for documentation) and shows understanding of the market and sales process, building investor confidence.

    It’s best to separate this document into necessary, wanted, and “nice to have” requirements. A device using software of sufficient complexity should have a software development and release plan. As opposed to hardware, software can have multiple releases and doesn’t need to be “all inclusive” upon launch. This provides a quicker path to market and a planned release for subsequent software versions. However, changes in software after FDA submission will follow a formal verification process, and new claims or intended uses cannot be added without triggering a new submission.

    If everything on the hardware side isn’t built in from the start, future versions should make allowances. For example, if the product needs to communicate with a cell phone, the original design should include both room for a Bluetooth module and the ability to communicate with it.

    With marketing requirements determined and product features decided, the FDA design control process begins. Engineering specifications are defined during the formal design input phase, and the device is assessed for hazards, single-fault failures, electrical safety, and usability. A feasibility system is a great start, but new risk mitigation requirements often alter the design during device assessment.

    A company’s quality system should cover design control processes. This means writing standard operating procedures and work instructions that describe management of design controls. This effort can be reduced if there is a plan to outsource development to groups with their own processes in place. However, there is still a responsibility to ensure the design control process is followed correctly. This is a common problem faced by first-time CEOs in the medtech world—as a medical device startup (from the FDA’s point of view), several areas must be under formal quality control.

    Creating value through quality involves following a quality system process and designing for quality. Quality processes don’t mitigate poor design skills or bad marketing decisions, and it’s essential to draw desires for a new product out of customers. Turning these marketing requirements into testable engineering specifications is a skill. Designing an elegant and intuitive instrument is an art.

    A product developed informally needs structure before it is ready for FDA review. This formal quality system around medical development is called design controls. It won’t be fully described here, but following is a list of the high level tasks:
    • Define customer requirements
    • Translate these requirements into design inputs
    • Perform a hazard analysis to determine how to mitigate identified risks
    • Design the device
    • Update requirements and review risks
    • Build the device per the design specifications

    • Verify that all requirements have been met
    • Validate that the product meets the user’s needs
    As mentioned, value is created both in following design controls and forging a robust design. Designing and building prototypes is where the rubber meets the road; it is a specialized discipline that requires attention to detail. An effective design follows a deliberate process, works within design constraints, incorporates new technology, involves theoretical and empirical work, designs for manufacturing, and creates an elegant solution (see “Value Engineering” in July/August’s issue of MPO).

    Despite this article walking a straight path to commercialization, development is anything but straightforward. Development is iterative, exploratory at times, involves discovery, and the devil is always in the details. During development, there is a tendency to explore alternative design paths, which are sometimes unclear. Good design teams know how to perform in ambiguity, but usually don’t know what is “good enough” for a product. This decision is determined by the marketing team, the original marketing requirements, and decisions made during the design and discovery process. It’s easy to lose focus in this area; here an experienced and effective project manager is essential.

    Once the design is finalized, careful requirement verification testing is important  to create a high-value product. It is important to prove a robust and long lasting design, beyond just verifying that the product meets its requirements. A formal process to uncover potential faults is called failure mode and effects analysis. A less formal (but perhaps even more effective) analysis is highly accelerated life testing (HALT), which is a practical, “See where it breaks” approach. The HALT process uses extreme temperature and vibration cycles to stress a prototype to failure—fix the failure and repeat until all weak points are identified. Once the design is robust enough, validation testing proves the final design meets the original marketing requirements (user needs).

    The last value inflection point is FDA submission and approval. This is the culmination of all previous design process efforts. For investors, it’s the most important milestone. The best value added adage here is, “Do it right the first time.” Cutting corners and taking shortcuts can work for a while, but can derail a project in the end.

    To recap, a list of value inflection points:
    • Intellectual property (IP)
    • Prove feasibility
    • Define market and product
    • Define technical requirements
    • Design and build prototypes
    • Finalize design, verify, and validate
    • FDA submission and approval
    Creating value during medical device design requires dedicated focus on inflection points. Without focus, design and development can drift and schedules can run out of control. Each point is critical to success and the team’s momentum. The path to commercialization may be a straight line of value inflection points, but the design process can take many paths; keeping the design team focused is the best way to create value. 


    Steve Maylish has been part of the medical device community for more than 30 years. He is currently chief commercial officer for Fusion Biotec, an Irvine, Calif.-based contract engineering firm that brings together art, science, and engineering to create medical devices. Early in his career, Maylish held positions at Fortune 100 corporations such as Johnson & Johnson, Shiley, Sorin Group, Baxter Healthcare, and Edwards Lifesciences.

    Bruce Sargeant is founder and CEO of Fusion Biotec Inc., a medical product development company located in Irvine, Calif. He has been an innovator and serial entrepreneur in the medical product outsourcing space for over three decades, since co-founding Ocean Scientific in 1980. Most recently he was CTO at BIT USA, a company created when BIT of Germany purchased Source Scientific and California Medtech.
    Related Searches
    • fda
    • medical product
    • product outsourcing
    • johnson
    Related Knowledge Center
    • Software & IT
    • R&D & Design
    • Testing
    Suggested For You
    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    EMS EMS' Engineering Resources Increasingly in Demand
    Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    Portable Medical Devices Market to Reach $100 Billion by 2027 Portable Medical Devices Market to Reach $100 Billion by 2027
    BD Receives 510(k) Clearance for Pristine Catheter BD Receives 510(k) Clearance for Pristine Catheter
    Medtronic Introduces Extended Infusion Set in Europe Medtronic Introduces Extended Infusion Set in Europe
    Mastering Motion for Robotic Surgical Systems—A Medtech Makers Q&A Mastering Motion for Robotic Surgical Systems—A Medtech Makers Q&A
    MICRO Expands with New Facility in Costa Rica MICRO Expands with New Facility in Costa Rica
    Qosina Announces Expanded Portfolio for Bioprocess Single-use Systems Qosina Announces Expanded Portfolio for Bioprocess Single-use Systems
    Elixir Medical Begins Study of Metallic Implant for CAD Treatment Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    Tooling Capabilities Tooling Capabilities
    Three Future Trends and Opportunities in Quality Assurance Three Future Trends and Opportunities in Quality Assurance
    Moving from Concept to Design—MPO Videobites Moving from Concept to Design—MPO Videobites
    Grant Issued for Development of 3D-Printed Resorbable Medical Implants Grant Issued for Development of 3D-Printed Resorbable Medical Implants
    BD to Invest $65M in Tucson, Arizona Supply Chain Hub BD to Invest $65M in Tucson, Arizona Supply Chain Hub

    Related Columns

    • Testing
      The Evolution of Chemical Characterization for Medical Devices

      The Evolution of Chemical Characterization for Medical Devices

      Evaluation of biological safety of devices is experiencing some of the most significant changes in history.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing 04.01.21

    • Software & IT
      Cybersecurity Compromises, Courtesy of COVID-19

      Cybersecurity Compromises, Courtesy of COVID-19

      As the healthcare industry focused its energies last year on battling SARS-CoV-2, cybercriminals used the distraction to their advantage.
      Michael Barbella, Managing Editor 03.04.21

    • Software & IT
      Three Ways to Fast-Track the Total Product Lifecycle

      Three Ways to Fast-Track the Total Product Lifecycle

      Here are three ways leaders including Alcon, Baxter Healthcare, Boston Scientific, Epredia, and Illumina are driving innovation in medtech.
      Seth Goldenberg, Ph.D., Vice President, MedTech, Veeva Systems 03.04.21


    • R&D & Design
      Six Questions to Consider in Developing a Home Healthcare Device

      Six Questions to Consider in Developing a Home Healthcare Device

      These design decisions stem from questions relative to in-home use and 60601-1-11 compliance.
      Rachael Scott, Lead Electrical Engineer, Key Tech 03.03.21

    • R&D & Design
      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, President & Founder, Empirical 02.03.21

    • Contract Manufacturing
      Use Vertical Integration to Increase Productivity, Drive Innovation

      Use Vertical Integration to Increase Productivity, Drive Innovation

      The concept of vertical integration is simple: a company combining two or more stages of production that would normally be operated by separate companies.
      Ryan Lipe, Senior Vice President of Sales & Marketing, MGS 02.03.21


    • Contract Manufacturing
      So Many Changes in Medtech, So Short a Time

      So Many Changes in Medtech, So Short a Time

      This article looks at the general state of medtech/life sciences M&A and the outsourcing trends triggered by the worldwide COVID-19 pandemic.
      Mark Bonifacio, President, BCS LLC 10.01.20

    • Contract Manufacturing | R&D & Design
      Trends for Medtech Contract R&D and Manufacturing

      Trends for Medtech Contract R&D and Manufacturing

      Over the past 10 years, medtech manufacturers from startups to giants have grown their levels of outsourcing to contract R&D and manufacturing partners.
      Maria Shepherd, President and Founder, Medi-Vantage 09.01.20

    • Contract Manufacturing
      Smart Sourcing: Transforming the Supply Chain Into a Value Network

      Smart Sourcing: Transforming the Supply Chain Into a Value Network

      The rise of globalization and outsourcing has led to increased supply chain risk and decreased predictability due to variability and complexity.
      Daniel R. Matlis and Sandra K. Rodriguez, Axendia Inc. 09.01.20


    • R&D & Design | Surgical
      Sparking Innovation as We Struggle to Find the New Normal

      Sparking Innovation as We Struggle to Find the New Normal

      The goal is to find the best ideas to support orthopedic patients adjusting to additional pain and immobility while they wait for elective surgeries.
      Dawn A. Lissy, Founder & President, Empirical 06.04.20

    • Contract Manufacturing
      Shopping Smart: What to Look for in a Contract Manufacturer

      Shopping Smart: What to Look for in a Contract Manufacturer

      A contract manufacturing organization can help shoulder the workload of bringing a new device to market.
      Claudio Hanna and Jennifer Ponti, Web Industries Inc. 06.04.20

    • R&D & Design
      Disposable Design: Consider All Interfaces

      Disposable Design: Consider All Interfaces

      The disposable component is becoming more challenging as products get smaller and more complex.
      Will DeMore, Mechanical Engineer, Key Technologies Inc. 06.04.20


    • Testing
      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Companies need to review their testing plan so it supports a successful submission, saves time, and ensures the long-term success of their product.
      Sherry Parker, Ph.D., Senior Director of Regulatory Toxicology, WuXi AppTec Medical Device Testing 06.04.20

    • Software & IT
      The Five Steps Toward Machine Learning

      The Five Steps Toward Machine Learning

      When talking about AI and ML, we’re no longer discussing the theoretical scenarios science fiction is made of. We’re talking about what’s possible.
      Sue Marchant, Machine Learning and Artificial Intelligence, MasterControl 05.01.20

    • R&D & Design
      Why Outsourcing Is in: Piecing Out Projects Makes Sense

      Why Outsourcing Is in: Piecing Out Projects Makes Sense

      Getting outside help is a trend both large and small medical device companies are following as outsourcing engineering services continues to gain traction.
      Dawn A. Lissy, President & Founder, Empirical 04.01.20


    Trending
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Harnessing Critical Health Data With Wearable Technology
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    • Gynesonics Appoints Susan Stimson to Its Board of Directors
    • Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    • Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology
    • Abbott Begins Shipping Rapid COVID Self-Tests
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Longvida Curcumin Extract Receives ANVISA Approval in Brazil
    Curcugen Curcumin Formulation Evidenced to Attenuate Post-Exercise Inflammation
    Good Rāz Launches Taste-Free Vitamin D3 Drops
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Releases Results of 2021 Green Building Community Survey
    PPG Publishes Sustainability Report
    Sherwin-Williams Launches Echelon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    Gynesonics Appoints Susan Stimson to Its Board of Directors
    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Evotec to Build Second Biologics Mfg. Facility in Toulouse
    Adare Pharma Names Ludger Roedder President of Adare Biome
    Johnson & Johnson 1Q Results
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Donginbi Launches Men’s Skincare Collection
    Kiehl’s Launches Pouch Refillables
    Skin Match Technology Partners with Men-Only Grooming Platforms
    Happi

    Latest Breaking News From Happi

    Robertet Appoints Reichert as Perfumer
    Kiehl’s Launches Sustainable Pouch Refillables for Hair Care, Skin Care
    New OTC Natural Hemp Pain Relief Gel Arrives at cbdMD
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PPG releases 2020 Sustainability Report
    GAA merges with AIMCAL
    Acucote expands Insights educational program
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Glatfelter GlatClean Nominated for World of Wipes Innovation Award
    P&G’s Sales Up 5%
    Ontex Tests Industrial Scale Diaper Composting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Spinal Elements' Lucent 3D Additive Manufactured Interbodies Earn FDA Nod
    Conformis, Paragon 28 Ink Licensing Deal
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints imec, Soitec Executives to Europe Advisory Board
    NREL Takes Novel Approach to 3D-Printed Water Power Prototypes
    Canatu Manufactures World’s Thinnest Free-standing CNB Membrane

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login